Showing results (1-10 of 98) with videos related to
Sort By:
Pageof 10
Brain Research|April 15, 2014
Oligonucleotide-based therapy for neurodegenerative diseasesIddo Magen, Eran HornsteinMolecular Therapy : the Journal of the American Society of Gene Therapy|March 7, 2026
Cell free miRNAs are pharmacodynamic biomarkers for enhanced Dicer activity by Enoxacin in human patients with Amyotrophic lateral sclerosisIddo Magen, Hannah Marlene Kaneb, Maria Masnata, et al.Med (New York, N.Y.)|November 22, 2025
IsomiR utility in amyotrophic lateral sclerosis prognosticationYahel Cohen, Ilan Sinai, Iddo Magen, et al.Medrxiv : the Preprint Server for Health Sciences|June 4, 2025
IsomiR Utility in Amyotrophic Lateral Sclerosis PrognosticationYahel Cohen, Ilan Sinai, Iddo Magen, et al.RNA Biology|September 19, 2018
Evaluation of methodologies for microRNA biomarker detection by next generation sequencingAnna M L Coenen-Stass, Iddo Magen, Tony Brooks, et al.Neuropeptides|November 12, 2013
Microtubule-stabilizing peptides and small molecules protecting axonal transport and brain function: focus on davunetide (NAP)Iddo Magen, Illana GozesCurrent Medicinal Chemistry|February 19, 2014
Davunetide: Peptide therapeutic in neurological disordersIddo Magen, Illana GozesNature Neuroscience|October 29, 2021
Circulating miR-181 is a prognostic biomarker for amyotrophic lateral sclerosisIddo Magen, Nancy Sarah Yacovzada, Eran Yanowski, et al.Neuropathology and Applied Neurobiology|June 15, 2023
microRNA-based predictor for diagnosis of frontotemporal dementiaIddo Magen, Nancy-Sarah Yacovzada, Jason D Warren, et al.Journal of Parkinson'S Disease|August 14, 2013
Mouse models of cognitive deficits due to alpha-synuclein pathologyIddo Magen, Marie-Françoise ChesseletPageof 10